Advertisement
Screener

Dimension Therapeutics, Inc. Capital Expenditures

Dimension Therapeutics, Inc. Capital Expenditures

Dimension Therapeutics, Inc. reported Capital Expenditures of $24.00 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-06.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2017-11-06

  • Dimension Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
  • Dimension Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
  • Dimension Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2017-03-31 was $24.00K, a 95.59% decline year-over-year.
  • Dimension Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2016-12-31 was $280.00K, a 21.57% decline year-over-year.
  • Dimension Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2016 was $6.72M, a 164.10% increase from fiscal 2015.
  • Dimension Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2015 was $2.54M, a 52.55% increase from fiscal 2014.
  • Dimension Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2014 was $1.67M.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 12 month
2017-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06
$0.00
derived: sum of 2 quarters · filed 2017-11-06
$24.00K
10-Q · filed 2017-11-06
$304.00K
derived: sum of 4 quarters · filed 2017-11-06
2017-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
$24.00K
10-Q · filed 2017-08-08
$304.00K
derived: sum of 3 quarters · filed 2017-08-08
$1.83M
derived: sum of 4 quarters · filed 2017-11-06
2017-03-31$24.00K
10-Q · filed 2017-05-10
$304.00K
derived: sum of 2 quarters · filed 2017-05-10
$1.83M
derived: sum of 3 quarters · filed 2017-11-06
$6.20M
derived: sum of 4 quarters · filed 2017-11-06
2016-12-31$280.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09
$1.81M
derived: sum of 2 quarters · filed 2017-11-06
$6.17M
derived: sum of 3 quarters · filed 2017-11-06
$6.72M
10-K · filed 2017-03-09
2016-09-30$1.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06
$5.89M
derived: sum of 2 quarters · filed 2017-11-06
$6.44M
10-Q · filed 2017-11-06
$6.79M
derived: sum of 4 quarters · filed 2017-11-06
2016-06-30$4.36M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
$4.91M
10-Q · filed 2017-08-08
$5.26M
derived: sum of 3 quarters · filed 2017-08-08
$5.43M
derived: sum of 4 quarters · filed 2017-08-08
2016-03-31$544.00K
10-Q · filed 2017-05-10
$901.00K
derived: sum of 2 quarters · filed 2017-05-10
$1.07M
derived: sum of 3 quarters · filed 2017-05-10
$2.27M
derived: sum of 4 quarters · filed 2017-05-10
2015-12-31$357.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09
$525.00K
derived: sum of 2 quarters · filed 2017-03-09
$1.73M
derived: sum of 3 quarters · filed 2017-03-09
$2.54M
10-K · filed 2017-03-09
2015-09-30$168.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
$1.37M
derived: sum of 2 quarters · filed 2016-11-10
$2.19M
10-Q · filed 2016-11-10
$2.65M
derived: sum of 4 quarters · filed 2017-03-09
2015-06-30$1.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11
$2.02M
10-Q · filed 2016-08-11
$2.49M
derived: sum of 3 quarters · filed 2017-03-09
2015-03-31$817.00K
10-Q · filed 2016-05-12
$1.29M
derived: sum of 2 quarters · filed 2017-03-09
2014-12-31$469.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09
$1.67M
10-K · filed 2017-03-09
2014-09-30$1.20M
10-Q · filed 2015-12-04